BACKGROUND: We sought to determine the location, expression, and characterization of cardiac stem cells (CSCs) in children with end-stage heart failure (ESHF). We hypothesized ESHF myocardium would contain an increased number of CSCs relative to age-matched healthy myocardium, and ESHF-derived CSCs would have diminished functional capacity as evidenced by reduced telomere length. METHODS: Tissue samples were obtained from the explanted hearts of children undergoing heart transplantation with ESHF, defined as New York Heart Association class III or IV and ejection fraction less than 0.20, and from age-matched congenital heart disease patients with normal myocardium. The expression profile of cardiac-specific stem cell markers was determined using quantitative real time polymerase chain reaction and immunofluorescence. Cardiac stem cell growth reserve was assessed with telomere length. RESULTS: There were 15 ESHF and 15 age-matched congenital heart disease patients. End-stage heart failure myocardium demonstrated increased expression of c-kit(+) and islet-1(+) CSCs by 2.0- and 2.5-fold, respectively, compared with myocardium from congenital heart disease patients. There was no difference in expression of c-kit(+) CSCs with advancing age from infants to children in ESHF myocardium. The c-kit(+) CSCs isolated from ESHF patients demonstrated significantly reduced telomere length, suggesting a diminished functional capability in these cells (8.1 ± 0.6 kbp versus 6.3 ± 0.3 kbp; p = 0.015). CONCLUSIONS: End-stage heart failure myocardium demonstrated an age-independent increase in CSCs relative to healthy myocardium; however, these CSCs from ESHF patients may have diminished proliferative ability and reduced functionality as an autologous cell therapy candidate. Further investigation is necessary to determine the role of ESHF-derived CSCs within the myocardium.
BACKGROUND: We sought to determine the location, expression, and characterization of cardiac stem cells (CSCs) in children with end-stage heart failure (ESHF). We hypothesized ESHF myocardium would contain an increased number of CSCs relative to age-matched healthy myocardium, and ESHF-derived CSCs would have diminished functional capacity as evidenced by reduced telomere length. METHODS: Tissue samples were obtained from the explanted hearts of children undergoing heart transplantation with ESHF, defined as New York Heart Association class III or IV and ejection fraction less than 0.20, and from age-matched congenital heart diseasepatients with normal myocardium. The expression profile of cardiac-specific stem cell markers was determined using quantitative real time polymerase chain reaction and immunofluorescence. Cardiac stem cell growth reserve was assessed with telomere length. RESULTS: There were 15 ESHF and 15 age-matched congenital heart diseasepatients. End-stage heart failure myocardium demonstrated increased expression of c-kit(+) and islet-1(+) CSCs by 2.0- and 2.5-fold, respectively, compared with myocardium from congenital heart diseasepatients. There was no difference in expression of c-kit(+) CSCs with advancing age from infants to children in ESHF myocardium. The c-kit(+) CSCs isolated from ESHFpatients demonstrated significantly reduced telomere length, suggesting a diminished functional capability in these cells (8.1 ± 0.6 kbp versus 6.3 ± 0.3 kbp; p = 0.015). CONCLUSIONS:End-stage heart failure myocardium demonstrated an age-independent increase in CSCs relative to healthy myocardium; however, these CSCs from ESHFpatients may have diminished proliferative ability and reduced functionality as an autologous cell therapy candidate. Further investigation is necessary to determine the role of ESHF-derived CSCs within the myocardium.
Authors: Stefan Rupp; Jürgen Bauer; Susanne von Gerlach; Stephan Fichtlscherer; Andreas M Zeiher; Stefanie Dimmeler; Dietmar Schranz Journal: Basic Res Cardiol Date: 2012-02-24 Impact factor: 17.165
Authors: Konrad Urbanek; Daniele Torella; Farooq Sheikh; Antonella De Angelis; Daria Nurzynska; Furio Silvestri; C Alberto Beltrami; Rossana Bussani; Antonio P Beltrami; Federico Quaini; Roberto Bolli; Annarosa Leri; Jan Kajstura; Piero Anversa Journal: Proc Natl Acad Sci U S A Date: 2005-06-02 Impact factor: 11.205
Authors: Rachana Mishra; Kalpana Vijayan; Evan J Colletti; Daniel A Harrington; Thomas S Matthiesen; David Simpson; Saik Kia Goh; Brandon L Walker; Graça Almeida-Porada; Deli Wang; Carl L Backer; Samuel C Dudley; Loren E Wold; Sunjay Kaushal Journal: Circulation Date: 2011-01-17 Impact factor: 29.690
Authors: Domenico D'Amario; Antonio M Leone; Antonio Iaconelli; Nicola Luciani; Mario Gaudino; Ramaswamy Kannappan; Melissa Manchi; Anna Severino; Sang Hun Shin; Francesca Graziani; Gina Biasillo; Andrea Macchione; Costantino Smaldone; Giovanni Luigi De Maria; Carlo Cellini; Andrea Siracusano; Lara Ottaviani; Massimo Massetti; Polina Goichberg; Annarosa Leri; Piero Anversa; Filippo Crea Journal: Circulation Date: 2013-11-18 Impact factor: 29.690
Authors: Philip D Tatman; Kathleen C Woulfe; Anis Karimpour-Fard; Danielle A Jeffrey; James Jaggers; Joseph C Cleveland; Karin Nunley; Matthew Rg Taylor; Shelley D Miyamoto; Brian L Stauffer; Carmen C Sucharov Journal: JCI Insight Date: 2017-07-20
Authors: Frehiwet T Hailu; Anis Karimpour-Fard; Lee S Toni; Michael R Bristow; Shelley D Miyamoto; Brian L Stauffer; Carmen C Sucharov Journal: Pediatr Res Date: 2021-05-19 Impact factor: 3.953